In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp.

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 2, 1999, Pages 283-286

  Ramos, Gema ^a   Cuenca Estrella, Manuel ^a   Monzón, Araceli ^a   Rodríguez Tudela, Juan L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDIASIS; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFICACY;

ANTIFUNGAL AGENTS; CANDIDA; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; QUINAZOLINES; TRIAZOLES;

EID: 0032771518     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.2.283     Document Type: Article

References (9)

1. Edwards, J. E., Bodley, G. P., Bowden, R. A., Buchner, T., DePauw, B. E., Filler, S. G. et al. (1997). International conference for the development of a consensus on the management and prevention of severe candidal infections. Clinical Infectious Diseases 25, 43-59.
2. Bartroli, J., Turmo, E., Algueró, M., Boncompte, M., Vericat, L., Conte, L., Ramis, J. et al. (1997). UR-9825: A new triazole derivative with potent broad-spectrum antifungal activity. In Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract E-67, p. 125. American Society for Microbiology, Washington, DC.
3. Bartroli, J., Turmo, E., Algueró, M., Boncompte, E., Vericat, M. L., Conte, L. et al. (1998). New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. Journal of Medical Chemistry 41, 1869-62.
4. Vericat, M. L., Algueró, M., Merlos, M., Pérez, L. L., Araño, A. & Forn, J. (1997). UR-9825, a novel broad spectrum triazole for treatment of fungal infections: oral activity In systemic mycoses. In Final Programme and Abstract Book Trends in Invasive Fungal Infections 4., Barcelona, Spain, 1997. Abstract P-94, p. 142. Imedex, The Netherlands.
5. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS, Villanova, PA.
6. Rodríguez-Tudela, J. L. & Martínez-Suárez, J. V. (1994). Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrobial Agents and Chemotherapy 38, 45-8.
7. Rodríguez-Tudela, J. L., Martínez-Suárez, J. V., Dronda, F., Laguna, F., Chaves, F. & Valencia, E. (1995). Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. Journal of Antimicrobial Chemotherapy 35, 793-804.
8. Barry, A. L. & Brown, S. D. (1996). In-vitro studies of two triazole antilungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species. Antimicrobial Agents and Chemotherapy 40, 1948-9.
9. McGinnis, M. R., Pasarell, L., Sutton, D. A., Fothergill, A. W., Cooper, C. R. & Rinaldi, M. G. (1997). In-vitro evaluation of voriconazole against some clinically important fungi. Antimicrobial Agents and Chemotherapy 41, 1832-4.